Showing results (571-580 of 624) with videos related to

Sort By:
Pageof 63
Leukemia|August 5, 2005
Gemtuzumab ozogamicin (Mylotarg) as single-agent treatment for frail patients 61 years of age and older with acute myeloid leukemia: final results of AML-15B, a phase 2 study of the European Organisation for Research and Treatment of Cancer and Gruppo Italiano Malattie Ematologiche dell'Adulto Leukemia GroupsS Amadori, S Suciu, R Stasi, et al.
Leukemia|May 17, 2003
The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)M Oosterveld, S Suciu, G Verhoef, et al.
Leukemia|September 1, 1996
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'AdultoV Liso, P Iacopino, G Avvisati, et al.
Bone Marrow Transplantation|April 20, 2004
Reassessing autotransplantation for acute myeloid leukaemia in first remission - a matched pair analysis of autologous marrow vs peripheral blood stem cellsB Sirohi, R Powles, S Kulkarni, et al.
Blood|October 6, 2001
Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDST de Witte, S Suciu, G Verhoef, et al.
British Journal of Haematology|November 25, 2000
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'AdultoM Montillo, A Tedeschi, L Pagano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) studyA Levis, A P Anselmo, A Ambrosetti, et al.
Blood|July 24, 2010
Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemiasHima Bansal, Sanjay Bansal, Manjeet Rao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung CancerAnna V Gaponova, Anna S Nikonova, Alexander Deneka, et al.
Oncogene|June 23, 2015
Resistance to HSP90 inhibition involving loss of MCL1 addictionS Busacca, E W P Law, I R Powley, et al.
Pageof 63